Corcept Therapeutics
CORT
#2992
Rank
A$7.65 B
Marketcap
A$71.33
Share price
10.53%
Change (1 day)
-36.82%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): A$68.18 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.76 Billion. a decrease over its 2024 earnings that were of A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 A$62.14 M-67.29%
2024 A$0.18 B27.66%
2023 A$0.14 B-4.75%
2022 A$0.15 B-9.51%
2021 A$0.17 B-2.91%
2020 A$0.17 B14.87%
2019 A$0.15 B24.71%
2018 A$0.12 B69.32%
2017 A$73.32 M419.26%
2016 A$14.12 M-395.64%
2015 -A$4.78 Million-87.53%
2014 -A$38.32 Million-33.44%
2013 -A$57.57 Million
2011 -A$44.86 Million17.84%
2010 -A$38.07 Million35.5%
2009 -A$28.1 Million2.84%
2008 -A$27.32 Million60.81%
2007 -A$16.99 Million-52.14%
2006 -A$35.5 Million20.91%
2005 -A$29.36 Million31.87%
2004 -A$22.26 Million60.54%
2003 -A$13.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.68 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.13 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.69 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.10 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.94 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$42.7 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$38.07 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.66 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA